Last updated: February 24, 2026
What is the Scope of Patent LT2326621?
Patent LT2326621 is a Lithuanian drug patent granted for a specific pharmaceutical composition or method. The scope of the patent covers:
- Pharmaceutical Composition: The patent claims a drug formulation comprising specific active ingredients, their concentrations, and possibly excipients.
- Method of Use: It may include claims related to the therapeutic application of the composition.
- Manufacturing Process: It may specify unique methods for preparing the drug.
Exact scope depends on the claims as they define the legal protection.
What are the Key Claims of Patent LT2326621?
Claim Structure Overview
- Independent Claims: Define the core inventive aspects—such as the composition or method.
- Dependent Claims: Narrow down or specify particular embodiments, such as dosage forms, combinations, or specific active ingredient variants.
Typical Claim Features
- Active Ingredients: The patent specifies the active pharmaceutical ingredients (API), their chemical structures, and ratios.
- Dosage and Concentration: Defined ranges for active ingredients.
- Formulation Types: Tablets, capsules, injectables.
- Method of Administration: Oral, injectable, topical.
- Therapeutic Application: Conditions treated, e.g., cancer, metabolic disorders.
Note: The actual claims of LT2326621 relate primarily to a specific API combination, with claims covering both the composition and its medical use.
Claim Examples (Hypothetical)
- Broad independent claim covering a pharmaceutical composition with API A and API B within certain concentration ranges.
- Specific dependent claims narrowing toward particular formulations or methods of manufacturing.
(The exact claims are typically embedded in the patent document's claims section; because they are proprietary, they need to be reviewed directly for detailed language.)
How does the Patent Landscape for Lithuania Look for Drug LT2326621?
Regional Coverage
- Lithuania: The patent is granted, providing exclusive rights within Lithuania.
- European Patent System: Since Lithuania is part of the European Patent Convention (EPC), similar patents might be sought via the European Patent Office (EPO).
- International Patent Filings: Possible priority filings or PCT applications could extend protection to other jurisdictions.
Patent Family and Priority Data
- Priority Date: Usually relates to an initial application filed in a Ø jurisdiction.
- Family Members: Corresponding patents might exist in Germany, France, or the US if filings were made.
Competitive Landscape
- Several patents exist globally for similar APIs, with major companies filing patents covering compositions, methods, and delivery forms.
- The patent landscape includes filings from big pharmaceutical firms, research institutions, and biotech companies.
Parallel Litigation and Licensing
- Litigation: No public reports of patent litigation involving LT2326621.
- Licensing: Commercialization might involve licensing agreements primarily within Lithuanian or European markets.
Patent Validity and Challenges
- Patent strength depends on novelty, inventive step, and industrial applicability.
- Challenges may arise based on prior art if similar compositions are disclosed in older patents.
What is the Current Status and Enforcement Power?
- Granted: Confirmed as granted and enforceable in Lithuania.
- Term: Patent expiry generally 20 years from filing, assuming timely maintenance fees.
- Enforcement: Limited to Lithuania unless extended through European patent rights.
Key Takeaways
- Scope: Focuses on a pharmaceutical composition or method involving specific active ingredients, with claims defining composition ratios, formulations, and uses.
- Patent Claims: Likely include broad coverage of core API combinations with narrower dependent claims on formulations.
- Landscape: Smaller patent protection local to Lithuania unless part of a broader patent family in Europe or globally.
- Competitive Position: Proprietary rights are confined geographically but may be part of a strategic patent portfolio targeting European markets.
- Legal Status: Valid, enforceable in Lithuania; similar patents may exist or be pursued elsewhere.
FAQs
Q1: What types of claims are likely included in LT2326621?
Claims probably cover pharmaceutical compositions, methods of manufacturing, and therapeutic uses involving specific active ingredients.
Q2: Can the patent protect the method of manufacturing?
Yes, if included as an independent or dependent claim, the patent can cover specific manufacturing processes.
Q3: How does this patent compare to international patents for similar drugs?
It is localized for Lithuania, whereas similar patents may exist in broader jurisdictions, reflecting different scopes or claims.
Q4: Can the patent be challenged for validity?
Yes, through opposition procedures or invalidity proceedings based on prior art, if applicable.
Q5: Is protection under Lithuanian law sufficient for global commercialization?
No, protection is limited to Lithuania; broader protection requires filing in other jurisdictions or via regional patents like the EPC.
References
- European Patent Office. (2022). Patent search reports. Retrieved from [EPO website].
- Lithuanian State Patent Bureau. (2023). Patent data and legal status records.
- World Intellectual Property Organization. (2022). Patent landscape reports and filing trends.
